Roger Sawhney
2021
In 2021, Roger Sawhney earned a total compensation of $981.2K as Chief Financial Officer at Omega Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $392,293 |
| Salary | $378,142 |
| Other | $50,785 |
| Total | $981,220 |
Sawhney received $392.3K in option awards, accounting for 40% of the total pay in 2021.
Sawhney also received $160K in non-equity incentive plan, $378.1K in salary and $50.8K in other compensation.
Rankings
In 2021, Roger Sawhney's compensation ranked 8,840th out of 12,415 executives tracked by ExecPay. In other words, Sawhney earned more than 28.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,840 out of 12,415 | 29th |
Division Manufacturing | 3,917 out of 5,505 | 29th |
Major group Chemicals And Allied Products | 1,727 out of 2,375 | 27th |
Industry group Drugs | 1,536 out of 2,096 | 27th |
Industry Biological Products, Except Diagnostic Substances | 335 out of 449 | 25th |
Source: SEC filing on April 29, 2022.
Sawhney's colleagues
We found two more compensation records of executives who worked with Roger Sawhney at Omega Therapeutics in 2021.